🔴 Pyxis Oncology is trading 5.4% down today as it retraces yesterday's gains

Pyxis Oncology is trading at $2.30 (5.4% down) as the stock gives back a portion of yesterday's gains in what appears to be a normal retracement.

• The decline follows a 6.1% rally in the previous session, with no fresh company-specific headlines, earnings, or FDA decisions reported this morning.
• The move comes amid a mixed broader market and follows a period of sharp volatility for the stock.
• Market analysts view the price action as a technical retracement rather than a reaction to fundamental news.